Specifications tableSubject areaEconomicsMore specific subject areaFinanceType of dataXLS files and tables in the article.How data was acquiredThe data on the firms share issues in the Brazilian market between 2004 and 2015 were gathered from the online database of the São Paulo Securities, Commodities, and Futures Exchange (BM&FBovespa) (<http://www.bmfbovespa.com.br>). The quarterly data for calculation of the control variables used in the models were obtained from the Economatica^®^, a private database. First, the data was collected and processed in Excel spreadsheets. Afterward, the statistical package STATA was used for data analysis.Data formatProcessed, analyzed.Experimental factorsWe excluded banks, insurers, insurance brokers, and investment funds due to the particular characteristics of their capital structure. Then, like other authors, we banned firms that presented the following conditions: (1) total assets worth less than R\$ 10 million; (2) missing accounting information in the main database used (Economatica^®^) that impairs the analysis; (3) book leverage higher than 1 (or 100%); and (4) market-to-book ratio higher than 10.Experimental featuresWe used descriptive statistics and linear regression models to analyze the relationship between market timing and abnormal returns. The statistical package STATA was used for data analysis. We lagged the control variables by one period to minimize multicollinearity and problems of heteroscedasticity. We also used robust variance/covariance matrices of the parameters (White\'s correction).Data source locationLaboratory of Finance and Risk (RiskFinLab), University of São Paulo (USP), School of Economics, Business and Accounting (FEA), Department of Accounting, São Paulo, Brazil.Data accessibilityData included in this article.Related research articleA relevant research article to this dataset is\
Gomes MC, Magnani VM, Albanez T & Valle MR, Effects of market timing on primary share issues in the Brazilian capital market. *The North-American Journal of Economics and Finance*, 49, 361--377 [@bib1].**Value of the data**•The dataset provided information about firms that carried out IPOs and follow-on offerings in the Brazilian market between 2004 and 2015, composed of 123 companies and 165 primary share issues: 97 initial public offerings and 68 follow-on offerings. This dataset is useful to investigate the determinants and consequences of firms' decisions for primary share issuance.•The dataset contains cross-sectional firm-level data such as the amount of capital raised, the number of shares issued, the price per share, firm size, tangibility, profitability, book leverage, market-to-book, and cumulative abnormal returns. Consequently, the dataset is particularly useful for those who study the effects of market timing on firms financing decisions. The data support, for example, a model that captures market timing behavior through cumulative abnormal returns and the impact of this behavior on the amount of proceeds raised, and can be applied and interpreted in other markets.•The dataset contains subsamples and different analysis time windows, indicating the dimension and characteristics of the Brazilian context, and may inspire researchers to explore developing issues related to the phenomenon of market timing behavior and its effects.

1. Data {#sec1}
=======

The data on the firms that carried out IPOs and follow-on offerings in the Brazilian market between 2004 and 2015 were gathered from the online database of the São Paulo Securities, Commodities and Futures Exchange (BM&FBovespa) (<http://www.bmfbovespa.com.br>). In this interval, there were 222 primary stock issues: 85 follow-on offerings and 137 IPOs. The final sample of firms came from a wide range of economic sectors.

To compose the final sample, we excluded banks, insurers, insurance brokers, and investment funds, due to the particular characteristics of their capital structure. Then, like other authors, we excluded firms that presented the following conditions: (1) total assets worth less than R\$ 10 million; (2) missing accounting information in the main database used (Economatica^®^) that impairs the analysis; (3) book leverage higher than 1 (or 100%); and (4) market-to-book ratio greater than 10. The final sample was composed of 123 companies and 165 primary share issues: 97 initial public offerings and 68 follow-on offerings. The quarterly data for calculation of the control variables, such as firm size, tangibility, profitability, book leverage, and market-to-book, were obtained from the Economatica^®^ database.

First, the data was collected and processed in Excel spreadsheets. Afterward, the statistical package STATA was used for data analysis. [Table 1](#tbl1){ref-type="table"} summarizes the calculation of each variable. [Table 2](#tbl2){ref-type="table"} presents the average values of the dependent variables for the sample with 68 follow-on offerings, and [Table 5](#tbl5){ref-type="table"} shows the average values for the complete sample. [Table 3](#tbl3){ref-type="table"}, [Table 4](#tbl4){ref-type="table"}, [Table 6](#tbl6){ref-type="table"}, [Table 7](#tbl7){ref-type="table"}, [Table 8](#tbl8){ref-type="table"}, [Table 9](#tbl9){ref-type="table"}, [Table 10](#tbl10){ref-type="table"}, [Table 11](#tbl11){ref-type="table"}, [Table 12](#tbl12){ref-type="table"} present the data of cross-sectional regressions for different model specifications.Table 1Description of dataset variables.Table 1VariablesAbbrev.Definition/Calculation**Dependent Variables**Amount of capital raised*Cap1*Capital raised/Total assetsNumber of shares issued*Cap2*No. of shares offered/No. of shares outstandingPrice per share*Cap3*Price per share offered/Book value of the share**Explanatory variables**Cumulative abnormal return before share issue*CAR1*~*t*~Obtained using monthly benchmark-adjusted returns before share issue, for three different windows (t = 6, 12 and 18 months)Cumulative abnormal return after share issue*CAR2*~*t*~Obtained using monthly benchmark-adjusted returns after share issue, for three different windows (t = 6, 12 and 18 months)Dummy for cumulative abnormal return before share issue*D_CAR1*~*t*~=1 for firms with positive CAR1 and zero otherwise, for each of the three different windows (t = 6, 12 and 18 months)Dummy for cumulative abnormal return after share issue*D_CAR2*~*t*~=1 for firms with negative CAR2 and zero otherwise, for each of the three different windows (t = 6, 12 and 18 months)Dummy for cumulative abnormal return before and after share issue*D_CAR1*~*t*~*\*D_CAR2*~*t*~=1 for firms with both D_CAR1 and D_CAR2 are 1, and zero otherwise, for each of the three different windows (t = 6, 12 and 18 months)**Control variables**Firm size*Size*ln(total assets)Tangibility*Tang*(Fixed assets -- Reval. Res.)/Total assetsProfitability*Prof*EBITDA/Total assetsBook leverage*Lev*DL/Total assetsMarket-to-book*M/B*Market value of assets/Book value of assetsSectorial market-to-book*M/Bs*Median of the M/B ratios of sector i at time t[^1]Table 2**Mean values and difference of means tests: sample with 68 follow-on offerings in the analysis of the D_CAR1**~**t**~. This table presents the average values of the dependent variables, segregated in the two groups of observations obtained by the measure *D_CAR1*~*t*~, along with the difference of means test (Mann-Whitney). Only the sample with 68 follow-on offerings was used in the analysis of the variable *D_CAR1*~*t*~ (*t* = 6, 12 and 18 months).Table 2VariableNStatisticCap1Cap2Cap3D_CAR1~6~= 1n = 47Mean0.1690.1711.212Standard Deviation0.1460.1460.146D_CAR1~6~= 0n = 21Mean0.1380.2580.745Standard Deviation0.2180.2180.218Mann-Whitney Test (z)(0.118)(0.332)(1.778)\*D_CAR1~12~= 1n = 54Mean0.1710.1871.153Standard Deviation0.1360.1360.136D_CAR1~12~= 0n = 14Mean0.1160.2390.738Standard Deviation0.2670.2670.267Mann-Whitney Test (z)(0.180)(0.174)(1.385)D_CAR1~18~= 1n = 58Mean0.1670.1811.158Standard Deviation0.1310.1310.131D_CAR1~18~= 0n = 10Mean0.1130.2910.543Standard Deviation0.3160.3160.316Mann-Whitney Test (z)(0.157)(0.321)(1.797)\*[^2]Table 3**Effect of abnormal returns on primary share issues: sample with 68 follow-on offerings, using the variable sectorial market-to-book ratio (M/Bs)**. This table presents the data of cross-sectional regression. Only the sample with 68 follow-on offerings was used in the analysis of the variable *CAR1*~*t*~ (*t* = 6, 12 and 18 months). The variables are those contained in Model 1, including the sectorial M/B (M/Bs) in place of the firm M/B, where *Y*~*ij*~ denotes the dependent variables *j Cap1*, *Cap2* and *Cap3*. Model 1.$Y_{ij} = \alpha + \beta_{1}\ \left( {CAR1} \right)_{i} + \beta_{2}\ \left( {M/Bs} \right)_{i} + \beta_{3}\ \left( {Tang} \right)_{i} + \ \beta_{4}\ \left( {Prof} \right)_{i} + \ \beta_{5}\ \left( {Size} \right)_{i} + \beta_{6\ }\left( {Lev} \right)_{i} + u_{i}$.Table 36 months12 months18 monthsCap1Cap2Cap3Cap1Cap2Cap3Cap1Cap2Cap3CAR1~6~0.0930.0320.014------------(0.004)\*\*\*(0.497)(0.921)------------CAR1~12~------0.0750.0160.062------------(0.006)\*\*\*(0.716)(0.589)------CAR1~18~------------0.027−0.0180.023------------(0.355)(0.578)(0.791)M/Bs0.026−0.0310.5990.024−0.0320.6010.018−0.0310.597(0.241)(0.250)(0.000)\*\*\*(0.263)(0.222)(0.000)\*\*\*(0.362)(0.211)(0.000)\*\*\*Tang0.0830.1010.0670.0870.1030.0660.0900.1030.069(0.018)\*\*(0.232)(0.748)(0.016)\*\*(0.218)(0.755)(0.015)\*\*(0.236)(0.744)Prof−0.252−0.7851.819−0.253−0.7771.774−0.254−0.7151.768(0.302)(0.044)\*\*(0.267)(0.320)(0.043)\*\*(0.288)(0.297)(0.066)\*(0.291)Size−0.0190.006−0.090−0.0180.005−0.081−0.028−0.002−0.088(0.054)\*(0.697)(0.017)\*\*(0.069)\*(0.753)(0.039)\*\*(0.012)\*\*(0.891)(0.022)\*\*Lev−0.1070.128−1.165−0.1300.116−1.148−0.1480.100−1.161(0.116)(0.165)(0.004)\*\*\*(0.049)\*\*(0.209)(0.004)\*\*\*(0.036)\*\*(0.280)(0.004)\*\*\*Const0.4260.1231.7770.4120.1531.5990.5880.2671.740(0.013)\*\*(0.638)(0.010)\*\*\*(0.016)\*\*(0.525)(0.019)\*\*(0.002)\*\*\*(0.234)(0.010)\*\*\*N686868686868686868Prob \> F0.000\*\*\*0.078\*0.000\*\*\*0.000\*\*\*0.092\*0.000\*\*\*0.000\*\*\*0.084\*0.000\*\*\*R^2^0.51293570.1650.5740.4960.1590.5760.3920.1620.575Estimation with robust matrixYesYesYesYesYesYesYesYesYes**Breusch-Pagan test**Chi^2^(1)7.2114.885.436.8813.225.6914.111.25.75Prob \> Chi^2^0.0072\*\*\*0.000\*\*\*0.020\*\*0.009\*\*\*0.000\*\*\*0.017\*\*0.000\*\*\*0.001\*\*\*0.0165\*\*[^3]Table 4**Effect of abnormal returns on primary share issues: sample with 68 follow-on offerings, without the variable market-to-book ratio (M/B)**. This table presents the data of cross-sectional regression. Only the sample with 68 follow-on offerings was used in the analysis of the variable *CAR1*~*t*~ (*t* = 6, 12 and 18 months). The variables are those contained in Model 1, without the variable market-to-book ratio (M/B), where *Y*~*ij*~ denotes the dependent variables *j Cap1*, *Cap2* and *Cap3*. Model 1.$Y_{ij} = \alpha + \beta_{1}\ \left( {CAR1} \right)_{i} + \beta_{2}\ \left( {Tang} \right)_{i} + \ \beta_{3}\ \left( {Prof} \right)_{i} + \ \beta_{4}\ \left( {Size} \right)_{i} + \beta_{5\ }\left( {Lev} \right)_{i} + u_{i}$.Table 46 months12 months18 monthsCap1Cap2Cap3Cap1Cap2Cap3Cap1Cap2Cap3CAR1~6~0.0920.034−0.029------------(0.007)\*\*\*(0.451)(0.847)------------CAR1~12~------0.0740.0170.036------------(0.000)\*\*\*(0.687)(0.788)------CAR1~18~------------0.028−0.0200.052------------(0.331)(0.538)(0.566)Tang0.0960.0850.3850.1000.0860.3830.1000.0860.384(0.006)\*\*\*(0.320)(0.175)(0.018)\*\*(0.305)(0.176)(0.008)\*\*\*(0.317)(0.175)Prof−0.086−0.9835.706−0.098−0.9815.674−0.138−0.9105.535(0.657)(0.003)\*\*\*(0.005)\*\*\*(0.661)(0.003)\*\*\*(0.006)\*\*\*(0.513)(0.009)\*\*\*(0.012)\*\*Size−0.0230.011−0.185−0.0220.010−0.174−0.0310.002−0.170(0.017)\*\*(0.433)(0.001)\*\*\*(0.005)\*\*\*(0.464)(0.002)\*\*\*(0.003)\*\*\*(0.844)(0.001)\*\*\*Lev−0.1280.153−1.658−0.1490.141−1.628−0.1620.123−1.612(0.065)\*(0.079)\*(0.001)\*\*\*(0.032)\*\*(0.110)(0.001)\*\*\*(0.028)\*\*(0.162)(0.001)\*\*\*Const0.5200.0103.9950.4990.0373.8030.6500.1643.741(0.001)\*\*\*(0.962)(0.000)\*\*\*(0.000)\*\*\*(0.849)(0.000)\*\*\*(0.000)\*\*\*(0.363)(0.000)\*\*\*N686868686868686868Prob \> F0.000\*\*\*0.060\*0.000\*\*\*0.000\*\*\*0.073\*0.000\*\*\*0.000\*\*\*0.065\*0.000\*\*\*R^2^0.4980.1540.4160.4830.1470.4160.3840.1510.418Estimation with robust matrixYesYesYesNoYesYesYesYesYes**Breusch-Pagan test**Chi^2^(1)4.0620.216.813.7718.297.4110.1613.567.88Prob \> Chi^2^0.044\*\*0.000\*\*\*0.009\*\*\*0.052\*0.000\*\*\*0.007\*\*\*0.001\*\*\*0.000\*\*\*0.005\*\*\*[^4]Table 5**Mean values and difference of means tests: total sample (IPOs and follow-on offerings) in the analysis of D_CAR2**~**t**~. This table presents the average values of the dependent variables, segregated in the two groups of observations obtained by the measure *D_CAR2*~*t*~, along with the difference of means test (Mann-Whitney). The complete sample was used in the analysis of the variable D\_*CAR2*~*t*~ (*t* = 6, 12 and 18 months).Table 5VariableNStatisticCap1Cap2Cap3D_CAR2~6~ = 1n = 80Mean0,3480,2591,538Standard Deviation0,1120,1120,112D_CAR2~6~ = 0n = 85Mean0,2790,2281,313Standard Deviation0,1080,1080,108Mann-Whitney Test (z)(0,445)(0.198)(1.441)\*D_CAR2~12~ = 1n = 84Mean0,3490,2511,525Standard Deviation0,1090,1090,109D_CAR2~12~ = 0n = 81Mean0,2750,2341,315Standard Deviation0,1110,1110,111Mann-Whitney Test (z)(0,478)(0.109)(1.349)D_CAR2~18~ = 1n = 82Mean0,3640,2571,611Standard Deviation0,1100,1100,110D_CAR2~18~ = 0n = 83Mean0,2620,2291,236Standard Deviation0,1100,1100,110Mann-Whitney Test (z)(0,652)(0.180)(2.410)\*\*[^5]Table 6**Effect of abnormal returns on primary share issues: total sample (IPOs and follow-on offerings), using the variable *CAR2***~***t***~**and sectorial market-to-book ratio (M/Bs)**. This table presents the data of cross-sectional regression. The complete sample was used in the analysis of the variable *CAR2*~*t*~ (*t* = 6, 12 and 18 months). The variables are those contained in Model 2, including the sectorial M/B (M/Bs) in place of the firm M/B, where *Y*~*ij*~ denotes the dependent variables *j Cap1*, *Cap2* and *Cap3*. Model 2.$Y_{ij} = \alpha + \beta_{1}\ \left( {CAR2} \right)_{i} + \beta_{2}\ \left( {M/Bs} \right)_{i} + \beta_{3}\ \left( {Tang} \right)_{i} + \ \beta_{4}\ \left( {Prof} \right)_{i} + \ \beta_{5}\ \left( {Size} \right)_{i} + \beta_{6\ }\left( {Lev} \right)_{i} + u_{i}$.Table 66 months12 months18 monthsCap1Cap2Cap3Cap1Cap2Cap3Cap1Cap2Cap3CAR2~6~−0.023−0.001−0.381------------(0.601)(0.985)(0.083)\*------------CAR2~12~------−0.058−0.031−0.103------------(0.026)\*\*(0.335)(0.429)------CAR2~18~------------−0.034−0.031−0.006------------(0.089)\*(0.155)(0.955)M/Bs0.016−0.0450.5780.013−0.0460.5690.012−0.0480.574(0.455)(0.025)\*\*(0.000)\*\*\*(0.541)(0.019)\*\*(0.000)\*\*\*(0.549)(0.017)\*\*(0.000)\*\*\*Tang0.0420.0210.4690.0400.0190.4640.0370.0170.468(0.426)(0.674)(0.074)\*(0.445)(0.691)(0.079)\*(0.475)(0.738)(0.078)\*Prof−0.381−0.2950.355−0.299−0.2460.325−0.335−0.2440.168(0.014)\*\*(0.009)\*\*\*(0.641)(0.056)\*(0.044)\*\*(0.680)(0.032)\*\*(0.032)\*\*(0.829)Size−0.105−0.030−0.208−0.104−0.029−0.209−0.104−0.028−0.211(0.000)\*\*\*(0.006)\*\*\*(0.000)\*\*\*(0.000)\*\*\*(0.007)\*\*\*(0.000)\*\*\*(0.000)\*\*\*(0.009)\*\*\*(0.000)\*\*\*Lev−0.0800.002−0.794−0.091−0.007−0.736−0.082−0.005−0.707(0.259)(0.980)(0.023)\*\*(0.188)(0.911)(0.036)\*\*(0.237)(0.937)(0.043)\*\*Const1.8190.7543.4911.8060.7473.4901.7990.7353.512(0.000)\*\*\*(0.000)\*\*\*(0.000)\*\*\*(0.000)\*\*\*(0.000)\*\*\*(0.000)\*\*\*(0.000)\*\*\*(0.000)\*\*\*(0.000)\*\*\*N165165165165165165165165165Prob \> F0.000\*\*\*0.000\*\*\*0.003\*\*\*0.000\*\*\*0.000\*\*\*0.004\*\*\*0.000\*\*\*0.000\*\*\*0.003\*\*\*R^2^0.5880.1120.4600.6000.1210.4510.5950.1270.449Estimation with robust matrixNoYesNoNoYesNoNoYesNo**Breusch-Pagan test**Chi^2^(1)1.54129.510.271.68129.250.982.1418.80.14Prob \> Chi^2^0.2140.000\*\*\*0.6040.1950.000\*\*\*0.3220.1430.000\*\*\*0.704[^6]Table 7**Effect of abnormal returns on primary share issues: total sample (IPOs and follow-on offerings), using the variable *CAR2***~***t***~**, without the variable market-to-book ratio (M/B)**. This table presents the data of cross-sectional regression. The complete sample was used in the analysis of the variable *CAR2*~*t*~ (*t* = 6, 12 and 18 months). The variables are those contained in Model 2, without the variable market-to-book ratio (M/B), where *Y*~*ij*~ denotes the dependent variables *j Cap1*, *Cap2* and *Cap3*. Model 2.$Y_{ij} = \alpha + \beta_{1}\ \left( {CAR2} \right)_{i} + \ \beta_{2}\ \left( {Tang} \right)_{i} + \ \beta_{3}\ \left( {Prof} \right)_{i} + \ \beta_{4}\ \left( {Size} \right)_{i} + \beta_{5\ }\left( {Lev} \right)_{i} + u_{i}$.Table 76 months12 months18 monthsCap1Cap2Cap3Cap1Cap2Cap3Cap1Cap2Cap3CAR2~6~−0.022−0.003−0.354------------(0.612)(0.948)(0.139)------------CAR2~12~------−0.059−0.027−0.146------------(0.023)\*\*(0.401)(0.277)------CAR2~18~------------−0.035−0.027−0.051------------(0.078)\*(0.222)(0.640)Tang0.050−0.0010.7450.046−0.0030.7330.043−0.0050.734(0.339)(0.988)(0.008)\*\*\*(0.371)(0.961)(0.070)\*(0.401)(0.915)(0.010)\*\*\*Prof−0.369−0.3280.781−0.288−0.2870.826−0.324−0.2860.679(0.017)\*\*(0.005)\*\*\*(0.346)(0.063)\*(0.025)\*\*(0.298)(0.036)\*\*(0.018)\*\*(0.420)Size−0.108−0.021−0.316−0.106−0.020−0.314−0.106−0.020−0.315(0.000)\*\*\*(0.021)\*\*(0.000)\*\*\*(0.000)\*\*\*(0.029)\*\*(0.000)\*\*\*(0.000)\*\*\*(0.038)\*\*(0.000)\*\*\*Lev−0.0940.042−1.317−0.1030.036−1.268−0.0940.039−1.240(0.167)(0.479)(0.000)\*\*\*(0.121)(0.527)(0.016)\*\*(0.159)(0.499)(0.001)\*\*\*Const1.8890.5526.1011.8630.5396.0401.8540.5256.055(0.000)\*\*\*(0.000)\*\*\*(0.000)\*\*\*(0.000)\*\*\*(0.000)\*\*\*(0.000)\*\*\*(0.000)\*\*\*(0.000)\*\*\*(0.000)\*\*\*N165165165165165165165165165Prob \> F0.000\*\*\*0.000\*\*\*0.015\*\*0.000\*\*\*0.000\*\*\*0.019\*\*0.000\*\*\*0.000\*\*\*0.017\*\*R^2^0.5860.0810.3520.5990.0880.3470.5940.0930.344Estimation with robust matrixNoYesNoNoYesYesNoYesNo**Breusch-Pagan test**Chi^2^(1)1.0271.232.751.2764.985.651.6761.453.61Prob \> Chi^2^0.3140.000\*\*\*0.097\*0.2600.000\*\*\*0.017\*\*0.1970.000\*\*\*0.057\*[^7]Table 8**Effect of abnormal returns on primary share issues: total sample (IPOs and follow-on offerings), using the variable D\_*CAR2***~***t***~**and sectorial market-to-book ratio (M/Bs)**. This table presents the data of cross-sectional regression. The complete sample was used in the analysis of the variable *D_CAR2*~*t*~ (*t* = 6, 12 and 18 months). The variables are those contained in Model 3, including the sectorial M/B (M/Bs) in place of the firm M/B, where *Y*~*ij*~ denotes the dependent variables *j Cap1*, *Cap2* and *Cap3*. Model 3.$Y_{ij} = \alpha + \beta_{1}\ \left( {D\_ CAR2} \right)_{i} + \beta_{2}\ \left( {M/Bs} \right)_{i} + \beta_{3}\ \left( {Tang} \right)_{i} + \ \beta_{4}\ \left( {Prof} \right)_{i} + \ \beta_{5}\ \left( {Size} \right)_{i} + \beta_{6\ }\left( {Lev} \right)_{i} + u_{i}$.Table 86 months12 months18 monthsCap1Cap2Cap3Cap1Cap2Cap3Cap1Cap2Cap3D_CAR2~6~0.0340.0160.189--------(0.158)(0.456)(0.101)--------D_CAR2~12~----0.0670.0140.154--------(0.006)\*\*\*(0.523)(0.101)----D_CAR2~18~--------0.0510.0200.188--------(0.034)\*\*(0.366)(0.055)\*M/Bs0.016−0.0440.5800.005−0.0470.5510.010−0.0470.554(0.429)(0.021)\*\*(0.012)\*\*(0.791)(0.016)\*\*(0.017)\*\*(0.633)(0.015)\*\*(0.016)\*\*Tang0.0420.0210.4680.0430.0210.4700.0420.0210.470(0.425)(0.669)(0.096)\*(0.411)(0.667)(0.097)\*(0.417)(0.666)(0.091)\*Prof−0.360−0.2800.339−0.279−0.2710.420−0.337−0.2740.364(0.020)\*\*(0.047)\*\*(0.698)(0.072)\*(0.061)\*(0.641)(0.028)\*\*(0.053)\*(0.689)Size−0.104−0.029−0.205−0.107−0.030−0.215−0.104−0.029−0.208(0.000)\*\*\*(0.000)\*\*\*(0.000)\*\*\*(0.000)\*\*\*(0.000)\*\*\*(0.000)\*\*\*(0.000)\*\*\*(0.000)\*\*\*(0.000)\*\*\*Lev−0.0770.001−0.720−0.092−0.002−0.747−0.0790.000−0.724(0.268)(0.992)(0.040)\*\*(0.179)(0.975)(0.036)\*\*(0.250)(0.999)(0.038)\*\*Const1.7830.7373.3071.8230.7553.5221.7870.7423.393(0.000)\*\*\*(0.000)\*\*\*(0.001)\*\*\*(0.000)\*\*\*(0.000)\*\*\*(0.000)\*\*\*(0.000)\*\*\*(0.000)\*\*\*(0.000)\*\*\*N165165165165165165165165165Prob \> F0.000\*\*\*0.000\*\*\*0.000\*\*\*0.000\*\*\*0.000\*\*\*0.000\*\*\*0.000\*\*\*0.000\*\*\*0.000\*\*\*R^2^0.5920.1150.4580.6060.1140.4550.5990.1160.458Estimation with robust matrixNoNoYesNoNoYesNoNoYes**Breusch-Pagan test**Chi^2^(1)0.71.27126.450.462.23134.110.112.72127.95Prob \> Chi^2^0.4020.2600.000\*\*\*0.4970.1350.000\*\*\*0.7360.099\*0.000\*\*\*[^8]Table 9**Effect of abnormal returns on primary share issues: total sample (IPOs and follow-on offerings), using the variable D\_*CAR2***~***t***~***,* without the variable market-to-book ratio (M/B)**. This table presents the data of cross-sectional regression. The complete sample was used in the analysis of the variable *D_CAR2*~*t*~ (*t* = 6, 12 and 18 months). The variables are those contained in Model 3, without the variable market-to-book ratio (M/B), where *Y*~*ij*~ denotes the dependent variables *j Cap1*, *Cap2* and *Cap3*. Model 3.$Y_{ij} = \alpha + \beta_{1}\ \left( {D\_ CAR2} \right)_{i} + \beta_{2}\ \left( {Tang} \right)_{i} + \ \beta_{3}\ \left( {Prof} \right)_{i} + \ \beta_{4}\ \left( {Size} \right)_{i} + \beta_{5\ }\left( {Lev} \right)_{i} + u_{i}$.Table 96 months12 months18 monthsCap1Cap2Cap3Cap1Cap2Cap3Cap1Cap2Cap3D_CAR2~6~0.0330.0180.166------------(0.152)(0.413)(0.175)------------D_CAR2~12~----0.0680.0050.264----------(0.003)\*\*\*(0.825)(0.033)\*\*------D_CAR2~18~--------0.0520.0130.266--------(0.028)\*\*(0.551)(0.020)\*\*Tang0.050−0.0010.7440.045−0.0010.7260.047−0.0010.730(0.354)(0.990)(0.064)\*(0.393)(0.982)(0.066)\*(0.358)(0.977)(0.062)\*Prof−0.349−0.3120.758−0.273−0.3221.013−0.328−0.3170.866(0.069)\*(0.029)\*\*(0.314)(0.154)(0.027)\*\*(0.184)(0.031)\*\*(0.027)\*\*(0.255)Size−0.107−0.021−0.313−0.108−0.021−0.317−0.106−0.021−0.307(0.000)\*\*(0.004)\*\*\*(0.000)\*\*(0.000)\*\*(0.003)\*\*\*(0.000)\*\*(0.000)\*\*(0.004)\*\*\*(0.000)\*\*Lev−0.0920.041−1.249−0.0970.042−1.266−0.0880.043−1.232(0.275)(0.506)(0.017)\*\*(0.240)(0.495)(0.015)\*\*(0.181)(0.487)(0.016)\*\*Const1.8580.5345.9481.8470.5495.9411.8300.5375.804(0.000)\*\*\*(0.000)\*\*\*(0.000)\*\*\*(0.000)\*\*\*(0.000)\*\*\*(0.000)\*\*\*(0.000)\*\*\*(0.000)\*\*\*(0.000)\*\*\*N165165165165165165165165165Prob \> F0.000\*\*\*0.000\*\*\*0.000\*\*\*0.000\*\*\*0.000\*\*\*0.000\*\*\*0.000\*\*\*0.000\*\*\*0.000\*\*\*R^2^0.5910.0840.3500.6060.0810.3600.5980.0830.360Estimation with robust matrixYesNoYesYesNoYesNoNoYes**Breusch-Pagan test**Chi^2^(1)4.930.7367.834.422.0576.92.772.2470.37Prob \> Chi^2^0.026\*\*0.3920.000\*\*\*0.026\*\*0.1520.000\*\*\*0.096\*0.1340.000\*\*\*[^9]Table 10**Effect of abnormal returns on primary share issues: robustness analysis with an alternative stock market return index for the sample with 68 follow-on offerings**. This table presents the data of cross-sectional regression. Only the sample with 68 follow-on offerings was used in the analysis of the variable *CAR1*~*t*~ (*t* = 6, 12 and 18 months). *CAR1*~*t*~ was calculated by the benchmark-adjusted monthly returns method, for which the abnormal return is the difference between the firm\'s stock return and the average market return. The average market return is represented by the Brazil 100 Index (IBrX 100). The variables are those contained in Model 1, where *Y*~*ij*~ denotes the dependent variables *j Cap1*, *Cap2* and *Cap3*. Model 1.$Y_{ij} = \alpha + \beta_{1}\ \left( {CAR1} \right)_{i} + \beta_{2}\ \left( {M/B} \right)_{i} + \beta_{3}\ \left( {Tang} \right)_{i} + \ \beta_{4}\ \left( {Prof} \right)_{i} + \ \beta_{5}\ \left( {Size} \right)_{i} + \beta_{6\ }\left( {Lev} \right)_{i} + u_{i}$.Table 106 months12 months18 monthsCap1Cap2Cap3Cap1Cap2Cap3Cap1Cap2Cap3CAR1~6~0.0910.031−0.021**------**(0.006)\*\*\*(0.458)(0.837)------------CAR1~12~**---**0.0720.0130.032**---**------(0.008)\*\*\*(0.762)(0.762)------CAR1~18~**------**0.026−0.0230.017------------(0.341)(0.506)(0.741)M/B0.014−0.0880.8580.013−0.0890.8600.010−0.0880.858(0.430)(0.004)\*\*\*(0.000)\*\*\*(0.428)(0.003)\*\*\*(0.000)\*\*\*(0.573)(0.004)\*\*\*(0.000)\*\*\*Tang0.0900.1170.0720.0950.1190.0700.0960.1190.070(0.012)\*\*(0.130)(0.605)(0.011)\*\*(0.121)(0.766)(0.011)\*\*(0.132)(0.622)Prof−0.192−0.324−0.691−0.188−0.314−0.727−0.202−0.246−0.748(0.419)(0.374)(0.403)(0.422)(0.386)(0.632)(0.393)(0.500)(0.373)Size−0.021−0.007−0.009−0.020−0.0090.000−0.029−0.016−0.003(0.033)\*\*(0.630)(0.803)(0.040)\*\*(0.499)(0.997)(0.007)\*\*\*(0.238)(0.925)Lev−0.1130.066−0.814−0.1360.052−0.788−0.1530.035−0.793(0.098)\*(0.459)(0.049)\*\*(0.049)\*\*(0.560)(0.052)\*(0.040)\*\*(0.700)(0.039)\*\*Const0.4600.4170.1040.4510.455−0.0590.6130.571−0.004(0.004)\*\*\*(0.108)(0.889)(0.006)\*\*\*(0.056)\*(0.945)(0.001)\*\*\*(0.017)\*\*(0.995)N686868686868686868Prob \> F0.000\*\*\*0.010\*\*\*0.000\*\*\*0.000\*\*\*0.012\*\*0.000\*\*\*0.000\*\*\*0.009\*\*\*0.000\*\*\*R^2^0.5030.2360.6960.4820.2290.6970.3830.2370.696Estimation with robust matrixYesYesYesYesYesNoYesYesYes**Breusch-Pagan test**Chi^2^(1)5.858.044.065.528.013.8211.0311.123.98Prob \> Chi^2^0.0155\*\*0.005\*\*\*0.044\*\*0.019\*\*0.005\*\*\*0.051\*0.001\*\*\*0.001\*\*\*0.046\*\*[^10]Table 11**Effect of abnormal returns on primary share issues: robustness analysis with an alternative stock market return index for the total sample, model with variable CAR2**~**t**~. This table presents the data of cross-sectional regression. The complete sample was used in the analysis of the variable *CAR2*~*t*~ (*t* = 6, 12 and 18 months). *CAR2*~*t*~ was calculated by the benchmark-adjusted monthly returns method, for which the abnormal return is the difference between the firm\'s stock return and the average market return. The average market return is represented by the Brazil 100 Index (IBrX 100). The variables are those contained in Model 2, where *Y*~*ij*~ denotes the dependent variables *j Cap1*, *Cap2* and *Cap3*. Model 2.$Y_{ij} = \alpha + \beta_{1}\ \left( {CAR2} \right)_{i} + \beta_{2}\ \left( {M/B} \right)_{i} + \beta_{3}\ \left( {Tang} \right)_{i} + \ \beta_{4}\ \left( {Prof} \right)_{i} + \ \beta_{5}\ \left( {Size} \right)_{i} + \beta_{6\ }\left( {Lev} \right)_{i} + u_{i}$.Table 116 months12 months18 monthsCap1Cap2Cap3Cap1Cap2Cap3Cap1Cap2Cap3CAR2~6~−0.0260.014−0.489------------(0.555)(0.750)(0.012)\*\*------------CAR2~12~------−0.056−0.027−0.126------------(0.031)\*\*(0.389)(0.277)------CAR2~18~------------−0.032−0.028−0.027------------(0.110)(0.190)(0.763)M/B0.039−0.0830.7700.037−0.0830.7530.037−0.0830.754(0.036)\*\*(0.000)\*\*\*(0.000)\*\*\*(0.040)\*\*(0.000)\*\*\*(0.000)\*\*\*(0.041)\*\*(0.000)\*\*\*(0.000)\*\*\*Tang0.0280.0460.3130.0250.0450.3080.0230.0420.310(0.596)(0.325)(0.170)(0.626)(0.340)(0.184)(0.663)(0.380)(0.184)Prof−0.421−0.225−0.206−0.344−0.175−0.226−0.382−0.175−0.383(0.007)\*\*\*(0.027)\*\*(0.757)(0.028)\*\*(0.123)(0.745)(0.014)\*\*(0.093)\*(0.578)Size−0.098−0.044−0.108−0.096−0.043−0.111−0.096−0.042−0.113(0.000)\*\*\*(0.000)\*\*\*(0.007)\*\*\*(0.000)\*\*\*(0.000)\*\*\*(0.006)\*\*\*(0.000)\*\*\*(0.000)\*\*\*(0.005)\*\*\*Lev−0.057−0.034−0.606−0.067−0.045−0.533−0.057−0.042−0.503(0.409)(0.575)(0.045)\*\*(0.328)(0.449)(0.081)\*(0.403)(0.481)(0.099)\*Const1.6621.0371.5921.6441.0231.6441.6381.0091.673(0.000)\*\*\*(0.000)\*\*\*(0.016)\*\*(0.000)\*\*\*(0.000)\*\*\*(0.014)\*\*(0.000)\*\*\*(0.000)\*\*\*(0.014)\*\*N165165165165165165165165165Prob \> F0.000\*\*\*0.000\*\*\*0.000\*\*\*0.000\*\*\*0.000\*\*\*0.000\*\*\*0.000\*\*\*0.000\*\*\*0.000\*\*\*R^2^0.5980.2150.5920.6080.2210.5780.6030.2270.575Estimation with robust matrixNoYesNoNoYesNoNoYesNo**Breusch-Pagan test**Chi^2^(1)2.1490.310.702.1778.790.852.6577.010.98Prob \> Chi^2^0.1470,000\*\*\*0.4020.1410.000\*\*\*0.3580.1040.000\*\*\*0.322[^11]Table 12**Effect of abnormal returns on primary share issues: robustness analysis with an alternative stock market return index for the total sample, model with variable D_CAR2**~**t**~. This table presents the data of cross-sectional regression. The complete sample was used in the analysis of the variable *D_CAR2*~*t*~ (*t* = 6, 12 and 18 months). *CAR2*~*t*~, which gave rise to the variable *D_CAR2*~t~, was calculated by the benchmark-adjusted monthly returns method, for which the abnormal return is the difference between the firm\'s stock return and the average market return. The average market return is represented by the Brazil 100 Index (IBrX 100). The variables are those contained in Model 3, where *Y*~*ij*~ denotes the dependent variables *j Cap1*, *Cap2* and *Cap3*. Model 3.$Y_{ij} = \alpha + \beta_{1}\ \left( {D\_ CAR2} \right)_{i} + \beta_{2}\ \left( {M/B} \right)_{i} + \beta_{3}\ \left( {Tang} \right)_{i} + \ \beta_{4}\ \left( {Prof} \right)_{i} + \ \beta_{5}\ \left( {Size} \right)_{i} + \beta_{6\ }\left( {Lev} \right)_{i} + u_{i}$.Table 126 months12 months18 monthsCap1Cap2Cap3Cap1Cap2Cap3Cap1Cap2Cap3D_CAR2~6~0.0390.0120.241**------**(0.099)\*(0.569)(0.024)\*\*------------D_CAR2~12~**--**0.0730.0270.167**---**----(0.002)\*\*\*(0.189)(0.085)\*------D_CAR2~18~**-----**0.0380.0160.170----------(0.108)(0.427)(0.067)\*M/B0.040−0.0820.7670.037−0.0830.7510.036−0.0840.744(0.030)\*\*(0.000)\*\*\*(0.000)\*\*\*(0.042)\*\*(0.000)\*\*\*(0.000)\*\*\*(0.052)\*(0.000)\*\*\*(0.000)\*\*\*Tang0.0300.0470.3280.0290.0470.3170.0290.0470.322(0.562)(0.304)(0.323)(0.570)(0.329)(0.340)(0.571)(0.303)(0.332)Prof−0.393−0.206−0.183−0.323−0.178−0.175−0.391−0.200−0.239(0.011)\*\*(0.123)(0.621)(0.034)\*\*(0.080)\*(0.652)(0.011)\*\*(0.135)(0.576)Size−0.096−0.043−0.104−0.098−0.043−0.114−0.097−0.043−0.111(0.000)\*\*\*(0.000)\*\*\*(0.001)\*\*\*(0.000)\*\*\*(0.000)\*\*\*(0.000)\*\*\*(0.000)\*\*\*(0.000)\*\*\*(0.000)\*\*\*Lev−0.060−0.040−0.551−0.066−0.043−0.533−0.057−0.040−0.523(0.380)(0.504)(0.220)(0.320)(0.481)(0.239)(0.405)(0.506)(0.241)Const1.6191.0201.4011.6261.0191.6011.6381.0221.565(0.000)\*\*\*(0.000)\*\*\*(0.007)\*\*\*(0.000)\*\*\*(0.000)\*\*\*(0.002)\*\*\*(0.000)\*\*\*(0.000)\*\*\*(0.002)\*\*\*N165165165165165165165165165Prob \> F0.000\*\*\*0.000\*\*\*0.000\*\*\*0.000\*\*\*0.000\*\*\*0.000\*\*\*0.000\*\*\*0.000\*\*\*0.000\*\*\*R^2^0.6040.2160.5890.6200.2230.5820.6030.2170.582Estimation with robust matrixNoNoYesNoYesYesNoNoYes**Breusch-Pagan test**Chi^2^(1)0.301.6787.580.594.0289.481.092.9883.91Prob \> Chi^2^0.5840.1960.000\*\*\*0.4410.045\*\*0.000\*\*\*0.2970.084\*0.000\*\*\*[^12]

Finally, the dataset of the supplementary file (Excel spreadsheet) contains the following contents: Sheet 1: Description of dataset variables and sample selection (named "Data in Brief"); Sheet 2: Source of data; Sheet 3: Sub-Sample for CAR1 (only SEO); Sheet 4: Total Sample for CAR2 (IPO + SEO); Sheet 5: Sub-Sample (D_CAR1xD_CAR2), SEO; Sheet 6: Graphs.

2. Experimental design, materials, and methods {#sec2}
==============================================

To calculate the abnormal return, we relied on the method employed by Ritter [@bib2], of monthly benchmark-adjusted returns, for which the abnormal return is the difference between the firm\'s stock return and the average market return. To ascertain the abnormal returns before and after the share issue, each month was defined by 21 successive trading days in relation to the issue date (event). Under this setup, month 1 consists of days 1--21 after the event, month 2 includes days 22--42 after the event, and so on, until reaching days 169--189 (6th month), 232--252 (12th month), and 358--378 (18th month) post-event. We used the same method for abnormal returns before the share issue, but with month 1 composed of the 21 trading days before the event, until reaching the 6th, 12th and 18th month prior to the issue date (days 169--189, 232--252 and 358--378, respectively). We used the Bovespa Index (Ibovespa) and Brazil 100 Index (IBrX 100) to calculate the average market return, i.e., the benchmark.

In this study, the monthly abnormal returns were grouped in three different windows (−6, +6; −12, +12; −18, +18) by the cumulative average abnormal return (CAR) technique. Since we calculated the CAR per company, represented by only one asset (one stock), instead of a portfolio of assets, the CAR was adjusted only in the interval to reflect the abnormal return of 6, 12, and 18 months. To classify the firms with negative and positive abnormal returns, before and after the stock issue in the three different windows, we applied two dummy variables. The dummy *D_CAR1*~*t*~ assumes value 1 when a firm i had a positive cumulative abnormal return before share issue, and 0 otherwise, in a time interval t of 6, 12 or 18 months. In turn, the dummy *D_CAR2*~*t*~ assumes value 1 for firm i that had a negative cumulative abnormal return after share issue and 0 otherwise, in the same three intervals.

We used descriptive statistics and linear regression models to analyze the relationship of market timing and abnormal returns. We lagged the control variables by one period to minimize multicollinearity and problems of heteroscedasticity. We also used robust variance/covariance matrices of the parameters (White\'s correction) for the hypothesis of the existence of heteroscedasticity.

[Table 2](#tbl2){ref-type="table"} shows the average values of the variables amount of capital raised (*Cap1*), number of shares issued (*Cap2*) and price per share (*Cap3*), segregated in the two groups of observations obtained by the measure *D_CAR1*~*t*~ for each of the three different windows (*t* = 6, 12 and 18 months), along with the difference of means test (Mann-Whitney). Since the sample analyzed was not normally distributed, we applied the nonparametric Mann-Whitney test, which permits comparing the means of independent samples extracted from the same population. The null hypothesis of this test is the absence of differences between the sampled groups [@bib3]. We calculated the variables *Cap1*, *Cap2*, and *Cap3* according to the work of Alti [@bib4]. Abnormal returns and cumulative abnormal returns were calculated by the benchmark-adjusted monthly returns following the method of Ritter [@bib2], as commented before.

[Table 3](#tbl3){ref-type="table"} shows the data of cross-sectional regression of Model 1 presented in Gomes et al. [@bib1]. However, the variables are those contained in Model 1, including the sectorial M/B (*M/Bs*) in place of the firm M/B. [Table 4](#tbl4){ref-type="table"} shows the data of cross-sectional regression of Model 1 but with the variable *M/B* deleted.

Similar to [Table 1](#tbl1){ref-type="table"}, [Table 5](#tbl5){ref-type="table"} shows the average values of the variables *Cap1*, *Cap2* and *Cap3*, segregated in the two groups of observations, now obtained by the measure *D_CAR2*~*t*~, which assumes value 1 for firms with negative cumulative abnormal return after share issue and 0 otherwise, for each of the three different windows (*t* = 6, 12 and 18 months), along with the difference of means test (Mann-Whitney). The variables *Cap1*, *Cap2* and *Cap3* were calculated according to the work of Alti [@bib4], while the abnormal returns were calculated following the method of Ritter [@bib2].

[Table 6](#tbl6){ref-type="table"} shows the data of cross-sectional regression of Model 2 presented in Gomes et al. [@bib1]. However, the variables are those contained in Model 2, including the sectorial M/B (*M/Bs*) in place of the firm M/B. [Table 7](#tbl7){ref-type="table"} shows the data of cross-sectional regression of Model 2 but with the variable *M/B* deleted.

[Table 8](#tbl8){ref-type="table"} shows the data of cross-sectional regression of Model 3 presented in Gomes et al. [@bib1]. However, the variables are those contained in Model 3, including the sectorial M/B (*M/Bs*) in place of the firm M/B. [Table 9](#tbl9){ref-type="table"} shows the data of cross-sectional regression of Model 2 but with the variable *M/B* deleted.

[Table 10](#tbl10){ref-type="table"}, [Table 11](#tbl11){ref-type="table"}, [Table 12](#tbl12){ref-type="table"} show the data of cross-sectional regression of Models 1, 2 and 3, respectively, with a change in the calculation of abnormal returns (*CAR1* and *CAR2*). Both *CAR1* and *CAR2* continue to be calculated by the benchmark-adjusted monthly returns method, for which the abnormal return is the difference between the firm\'s stock return and the average market return, but now the Brazil Index 100 (IBrX 100) is used instead of the Ibovespa to represent the average market return.
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The following is the supplementary data to this article:

Supplementary data to this article can be found online at [www.tatianaalbanez.com/data](http://www.tatianaalbanez.com/data){#intref0020} or <https://docs.wixstatic.com/ugd/4b053e_25c87bc429614a87a13387d7c334b58c.xlsx?dn=Data%20in%20Brief_Gomes%20et%20al.%20(2019).xlsx>.Multimedia component 1Multimedia component 1

We acknowledge the financial support from Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - Brasil (CAPES) - Finance Code 001 - and the Department of Accounting (FEA-RP) - University of São Paulo (USP) - for access to the Economatica dataset and all necessary support.

Supplementary data to this article can be found online at <https://doi.org/10.1016/j.dib.2019.104251>.

[^1]: Notes: *Ln*, natural logarithm; *Reval. Res.*, revaluation reserve; *EBITDA*, earnings before interest, taxes, depreciation and amortization; *DL*, debt liabilities, composed of short- and long-term loans, bonds and commercial lease obligations.

[^2]: Notes: *Cap1* is the amount of capital raised; *Cap2* is the number of shares issued; *Cap3* is the price per share. *D_CAR1*~*t*~ = 1 for positive cumulative abnormal return before the share issue and 0 otherwise, (*t* = 6, 12 and 18 months). For rejection of the null hypothesis of no difference in means: \*\*\*significance at 1%; \*\* significance at 5%; \* significance at 10%.

[^3]: Notes: *Cap1* is the amount of capital raised; *Cap2* is the number of shares issued; *Cap3* is the price per share. *CAR1*~*t*~ is the cumulative abnormal return before share issue, where *t* = 6, 12 and 18 months. *M/Bs* is sectorial market-to-book ratio; *Tang* is tangibility; *Prof* is profitability; *Size* is firm size; and *Lev* is book leverage. The variables *Tang*, *Prof*, *Size* and *Lev* were lagged by one quarter. We assumed significance of 5% in the Breusch-Pagan test for heteroscedasticity, i.e., when H~0~: homoscedasticity is rejected. The regression was performed by robust standard errors to correct the standard deviation for the possible presence of heteroscedasticity (White\'s correction). The table presents the linear coefficient of each explanatory variable followed by the p-value in parentheses. For rejection of the null hypothesis of coefficient equal to zero: \*\*\*significance at 1%; \*\* significance at 5%; \* significance at 10%.

[^4]: Notes: *Cap1* is the amount of capital raised; *Cap2* is the number of shares issued; *Cap3* is the price per share. *CAR1*~*t*~ is cumulative abnormal return before share issue, where *t* = 6, 12 and 18 months. *Tang* is tangibility; *Prof* is profitability; *Size* is firm size; and *Lev* is book leverage. The variables *Tang*, *Prof*, *Size* and *Lev* were lagged by one quarter. We assumed significance of 5% in the Breusch-Pagan test for heteroscedasticity, i.e., when H~0~: homoscedasticity is rejected. The regression was performed by robust standard errors to correct the standard deviation for the possible presence of heteroscedasticity (White\'s correction). The table presents the linear coefficient of each explanatory variable followed by the p-value in parentheses. For rejection of the null hypothesis of coefficient equal to zero: \*\*\*significance at 1%; \*\* significance at 5%; \* significance at 10%.

[^5]: Notes: *Cap1* is the amount of capital raised; *Cap2* is the number of shares issued; *Cap3* is the price per share. *D_CAR2*~*t*~ = 1 for negative cumulative abnormal return after the share issue and 0 otherwise, *(t* = 6, 12 and 18 months). For rejection of the null hypothesis of no difference in means: \*\*\*significance at 1%; \*\* significance at 5%; \* significance at 10%.

[^6]: Notes: *Cap1* is the amount of capital raised; *Cap2* is the number of shares issued; *Cap3* is the price per share. *CAR2*~*t*~ is accumulative abnormal return after share issue, where *t* = 6, 12 and 18 months. *M/Bs* is sectorial market-to-book ratio; *Tang* is tangibility; *Prof* is profitability; *Size* is firm size; and *Lev* is book leverage. The variables *Tang*, *Prof*, *Size* and *Lev* were lagged by one quarter. We assumed significance of 5% in the Breusch-Pagan test for heteroscedasticity, i.e., when H~0~: homoscedasticity is rejected. The regression was performed by robust standard errors to correct the standard deviation for the possible presence of heteroscedasticity (White\'s correction). The table presents the linear coefficient of each explanatory variable followed by the p-value in parentheses. For rejection of the null hypothesis of coefficient equal to zero: \*\*\*significance at 1%; \*\* significance at 5%; \* significance at 10%.

[^7]: Notes: *Cap1* is the amount of capital raised; *Cap2* is the number of shares issued; *Cap3* is the price per share. *CAR2*~*t*~ is accumulative abnormal return after share issue, where *t* = 6, 12 and 18 months. *Tang* is tangibility; *Prof* is profitability; *Size* is firm size; and *Lev* is book leverage. The variables *Tang*, *Prof*, *Size* and *Lev* were lagged by one quarter. We assumed significance of 5% in the Breusch-Pagan test for heteroscedasticity, i.e., when H~0~: homoscedasticity is rejected. The regression was performed by robust standard errors to correct the standard deviation for the possible presence of heteroscedasticity (White\'s correction). The table presents the linear coefficient of each explanatory variable followed by the p-value in parentheses. For rejection of the null hypothesis of coefficient equal to zero: \*\*\*significance at 1%; \*\* significance at 5%; \* significance at 10%.

[^8]: Notes: *Cap1* is the amount of capital raised; *Cap2* is the number of shares issued; *Cap3* is the price per share. D\_*CAR2*~*it*~ assumes value 1 for firms that had negative cumulative abnormal return after the primary issue and 0 otherwise, in a time interval *t* of 6, 12 and 18 months. *M/Bs* is sectorial market-to-book ratio; *Tang* is tangibility; *Prof* is profitability; *Size* is firm size; and *Lev* is book leverage. The variables *Tang*, *Prof*, *Size* and *Lev* were lagged by one quarter. We assumed significance of 5% in the Breusch-Pagan test for heteroscedasticity, i.e., when H~0~: homoscedasticity is rejected. The regression was performed by robust standard errors to correct the standard deviation for the possible presence of heteroscedasticity (White\'s correction). The table presents the linear coefficient of each explanatory variable followed by the p-value in parentheses. For rejection of the null hypothesis of coefficient equal to zero: \*\*\*significance at 1%; \*\* significance at 5%; \* significance at 10%.

[^9]: Notes: *Cap1* is the amount of capital raised; *Cap2* is the number of shares issued; *Cap3* is the price per share. D\_*CAR2*~*it*~ assumes value 1 for firms that had a negative cumulative abnormal return after the primary issue and 0 otherwise, in a time interval *t* of 6, 12 and 18 months. *Tang* is tangibility; *Prof* is profitability; *Size* is firm size; and *Lev* is book leverage. The variables *Tang*, *Prof*, *Size* and *Lev* were lagged by one quarter. We assumed significance of 5% in the Breusch-Pagan test for heteroscedasticity, i.e., when H~0~: homoscedasticity is rejected. The regression was performed by robust standard errors to correct the standard deviation for the possible presence of heteroscedasticity (White\'s correction). The table presents the linear coefficient of each explanatory variable followed by the p-value in parentheses. For rejection of the null hypothesis of coefficient equal to zero: \*\*\*significance at 1%; \*\* significance at 5%; \* significance at 10%.

[^10]: Notes: *Cap1* is the amount of capital raised; *Cap2* is the number of shares issued; *Cap3* is the price per share. *CAR1*~*t*~ is the cumulative abnormal return before share issue, where *t* = 6, 12 and 18 months. *M/B* is firm market-to-book ratio; *Tang* is tangibility; *Prof* is profitability; *Size* is firm size; and *Lev* is book leverage. The variables *Tang*, *Prof*, *Size* and *Lev* were lagged by one quarter. We assumed significance of 5% in the Breusch-Pagan test for heteroscedasticity, i.e., when H~0~: homoscedasticity is rejected. The regression was performed by robust standard errors to correct the standard deviation for the possible presence of heteroscedasticity (White\'s correction). The table presents the linear coefficient of each explanatory variable followed by the p-value in parentheses. For rejection of the null hypothesis of coefficient equal to zero: \*\*\*significance at 1%; \*\* significance at 5%; \* significance at 10%.

[^11]: Notes: *Cap1* is the amount of capital raised; *Cap2* is the number of shares issued; *Cap3* is the price per share. *CAR2~t~* is the cumulative abnormal return after share issue, where *t* = 6, 12 and 18 months. *M/B* is firm market-to-book ratio; *Tang* is tangibility; *Prof* is profitability; *Size* is firm size; and *Lev* is book leverage. The variables *Tang*, *Prof*, *Size* and *Lev* were lagged by one quarter. We assumed significance of 5% in the Breusch-Pagan test for heteroscedasticity, i.e., when H~0~: homoscedasticity is rejected. The regression was performed by robust standard errors to correct the standard deviation for the possible presence of heteroscedasticity (White\'s correction). The table presents the linear coefficient of each explanatory variable followed by the p-value in parentheses. For rejection of the null hypothesis of coefficient equal to zero: ∗∗∗significance at 1%; ∗∗ significance at 5%; ∗ significance at 10%.

[^12]: Notes: *Cap1* is the amount of capital raised; *Cap2* is the number of shares issued; *Cap3* is the price per share. D\_*CAR2*~*it*~ assumes value 1 for firms that had a negative cumulative abnormal return after the primary issue and 0 otherwise, in a time interval *t* of 6, 12 and 18 months. *M/B* is firm market-to-book ratio; *Tang* is tangibility; *Prof* is profitability; *Size* is firm size; and *Lev* is book leverage. The variables *Tang*, *Prof*, *Size* and *Lev* were lagged by one quarter. We assumed significance of 5% in the Breusch-Pagan test for heteroscedasticity, i.e., when H~0~: homoscedasticity is rejected. The regression was performed by robust standard errors to correct the standard deviation for the possible presence of heteroscedasticity (White\'s correction). The table presents the linear coefficient of each explanatory variable followed by the p-value in parentheses. For rejection of the null hypothesis of coefficient equal to zero: \*\*\*significance at 1%; \*\* significance at 5%; \* significance at 10%.
